Le Lézard
Classified in: Business, Covid-19 virus
Subjects: EARNINGS, Conference Call, Webcast

Limbach Holdings, Inc. Reports Second Quarter 2022 Results


Limbach Holdings, Inc. (Nasdaq: LMB) today announced its financial results for the quarter ended June 30, 2022. The company reported consolidated revenue of $116.1 million, which was a decrease of 4.0% compared to the second quarter of 2021. ODR segment revenue accounted for 42.9% of consolidated revenue in the second quarter of 2022, an increase of 48.7% over the second quarter of 2021, while contributing approximately 59.2% of consolidated gross profit. Consolidated gross margin improved to 18.4% from 15.4% for the second quarter of 2021 and drove a $2.6 million increase in gross profit year-over-year.

Charlie Bacon, Limbach's President and Chief Executive Officer, said, "Our second quarter results reflect the rapid growth of our ODR segment, which combined with continued improved execution in the GCR segment resulted in on-going improvement in consolidated gross profit margins. We also realized increased billing activity, which drove a sharp increase in operating cash flow. We are well ahead of schedule in our efforts to achieve a 50/50-GCR/ODR segment revenue mix by 2025. Year to date, ODR revenue accounted for 40.1% of our consolidated total, with the figure hitting 42.9% in the second quarter. The accelerated ODR growth this year has been a function of strong demand for both project and T&M work along with the contribution of Jake Marshall's ODR business. I should also note that we believe 2022 is playing out as expected, with the back half of the year being our larger revenue and profit generator, similar to last year. We also settled one of our smaller claim matters, which positively impacted earnings for the quarter."

Mr. Bacon continued, "Our December 2021 acquisition of Jake Marshall continues to meet our expectations. The industrial market, in which Jake Marshall is a regional leader, seems to be accelerating given a variety of factors, including onshoring and better domestic access to raw materials such as comparatively cheaper and abundant natural gas and electricity. We think that's particularly relevant in the Tennessee Valley, and the frequent announcements of plant relocations and new plant expansions is encouraging."

Mr. Bacon concluded, "In addition to setting the stage for profitable growth over time, we believe our strategic transformation has us well-positioned for a recession. Our business is diverse, from end markets we serve to our long-term customers to our diversity of service offerings. Thus far in 2022, we have seen customers react to inflationary pressures and supply chain constraints by focusing their spending on maintenance of existing equipment and we are well-positioned to provide those services. Additionally, we work with a variety of blue-chip customers that we expect will continue to invest in their facilities and equipment, with building systems being essential to their businesses. As a result, we are reconfirming our financial guidance for the year, which includes estimated revenue of $510 million to $540 million and Adjusted EBITDA of $25 million to $29 million."

The following are results for the three months ended June 30, 2022 compared to the three months ended June 30, 2021:

Balance Sheet and Backlog

At June 30, 2022, we had cash and cash equivalents of $19.7 million. We had current assets of $201.9 million and current liabilities of $142.1 million at June 30, 2022, representing a current ratio of 1.42x compared to 1.49x at December 31, 2021. Working capital was $59.8 million at June 30, 2022, a decrease of $3.4 million from December 31, 2021. At June 30, 2022, we had $3.5 million in borrowings against our revolving credit facility and $3.3 million for standby letters of credit, and carried a term loan balance of $25.7 million. During the quarter, we made $7.3 million of required principal payments on our term loan which reduced our outstanding balance.

Total backlog at June 30, 2022 was $428.1 million as compared to $435.2 million as of December 31, 2021. At June 30, 2022, GCR and ODR segment backlog accounted for $308.8 million and $119.3 million of that consolidated total, respectively. At December 31, 2021, GCR and ODR segment backlog accounted for $337.2 million and $98.0 million of that consolidated total, respectively.

2022 Guidance

We affirm our guidance for FY 2022 as follows:

Revenue

   

$510 million - $540 million

Adjusted EBITDA

   

$25 million - $29 million

With respect to projected 2022 Adjusted EBITDA, a quantitative reconciliation is not available without unreasonable effort due to the high variability, complexity and low visibility with respect to taxes and other items, which are excluded from Adjusted EBITDA. We expect the variability of this item to have a potentially unpredictable, and potentially significant, impact on future GAAP financial results.

Conference Call Details

Date:

Wednesday, August 10, 2022

Time:

9:00 a.m. Eastern Time

Participant Dial-In Numbers:

Domestic callers:

(877) 407-6176

International callers:

(201) 689-8451

Access by Webcast

The call will also be simultaneously webcast over the Internet via the "Investor Relations" section of Limbach's website at www.limbachinc.com or by clicking on the conference call link: https://event.choruscall.com/mediaframe/webcast.html?webcastid=CvhhJkPn. An audio replay of the call will be archived on Limbach's website for 365 days.

About Limbach

Limbach is an integrated building systems solutions firm whose expertise is in the design, modular prefabrication, installation, management and maintenance of heating, ventilation, air-conditioning ("HVAC"), mechanical, electrical, plumbing and controls systems. Our market sectors primarily include the following: healthcare, life sciences, data centers, industrial and light manufacturing, entertainment, education and government. With 22 offices throughout the United States and Limbach's full life-cycle capabilities, from concept design and engineering through system commissioning and recurring 24/7 service and maintenance, Limbach is positioned as a value-added and essential partner for building owners, construction managers, general contractors and energy service companies.

Forward-Looking Statements

We make forward-looking statements in this press release within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to expectations or forecasts for future events, including, without limitation, our earnings, Adjusted EBITDA, revenues, expenses, backlog, capital expenditures or other future financial or business performance or strategies, results of operations or financial condition, and in particular statements regarding the impact of the COVID-19 pandemic on the construction industry in the first half of 2022 and future periods, timing of the recognition of backlog as revenue, the potential for recovery of cost overruns, and the ability of Limbach to successfully remedy the issues that have led to write-downs in various business units. These statements may be preceded by, followed by or include the words "may," "might," "will," "will likely result," "should," "estimate," "plan," "project," "forecast," "intend," "expect," "anticipate," "believe," "seek," "continue," "target" or similar expressions. These forward-looking statements are based on information available to us as of the date they were made and involve a number of risks and uncertainties which may cause them to turn out to be wrong. Some of these risks and uncertainties may in the future be amplified by the COVID-19 outbreak and there may be additional risks that we consider immaterial or which are unknown. Accordingly, forward-looking statements should not be relied upon as representing our views as of any subsequent date, and we do not undertake any obligation to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. As a result of a number of known and unknown risks and uncertainties, our actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Please refer to our most recent annual report on Form 10-K, as well as our subsequent filings on Form 10-Q and Form 8-K, which are available on the SEC's website (www.sec.gov), for a full discussion of the risks and other factors that may impact any forward-looking statements in this press release.

LIMBACH HOLDINGS, INC.

Condensed Consolidated Statements of Operations (Unaudited)

 

 

 

Three Months Ended
June 30,

 

Six Months Ended
June 30,

(in thousands, except share and per share data)

 

2022

 

2021

 

2022

 

2021

Revenue

 

$

116,120

 

 

$

121,019

 

 

$

230,942

 

 

$

234,363

 

Cost of revenue

 

 

94,800

 

 

 

102,329

 

 

 

191,282

 

 

 

198,444

 

Gross profit

 

 

21,320

 

 

 

18,690

 

 

 

39,660

 

 

 

35,919

 

Operating expenses:

 

 

 

 

 

 

 

 

Selling, general and administrative

 

 

18,690

 

 

 

17,232

 

 

 

37,424

 

 

 

34,377

 

Change in fair value of contingent consideration

 

 

765

 

 

 

?

 

 

 

765

 

 

 

?

 

Amortization of intangibles

 

 

399

 

 

 

104

 

 

 

798

 

 

 

208

 

Total operating expenses

 

 

19,854

 

 

 

17,336

 

 

 

38,987

 

 

 

34,585

 

Operating income

 

 

1,466

 

 

 

1,354

 

 

 

673

 

 

 

1,334

 

Other (expenses) income:

 

 

 

 

 

 

 

 

Interest expense, net

 

 

(478

)

 

 

(452

)

 

 

(964

)

 

 

(1,716

)

Gain on disposition of property and equipment

 

 

147

 

 

 

94

 

 

 

111

 

 

 

8

 

Loss on early termination of operating lease

 

 

(32

)

 

 

?

 

 

 

(849

)

 

 

?

 

Loss on early debt extinguishment

 

 

?

 

 

 

?

 

 

 

?

 

 

 

(1,961

)

Gain on change in fair value of warrant liability

 

 

?

 

 

 

?

 

 

 

?

 

 

 

14

 

Total other expenses

 

 

(363

)

 

 

(358

)

 

 

(1,702

)

 

 

(3,655

)

Income (loss) before income taxes

 

 

1,103

 

 

 

996

 

 

 

(1,029

)

 

 

(2,321

)

Income tax provision (benefit)

 

 

237

 

 

 

264

 

 

 

(379

)

 

 

(771

)

Net income (loss)

 

$

866

 

 

$

732

 

 

$

(650

)

 

$

(1,550

)

 

 

 

 

 

 

 

 

 

Earnings Per Share ("EPS")

 

 

 

 

 

 

 

 

Earnings (loss) per common share:

 

 

 

 

 

 

 

 

Basic

 

$

0.08

 

 

$

0.07

 

 

$

(0.06

)

 

$

(0.16

)

Diluted

 

$

0.08

 

 

$

0.07

 

 

$

(0.06

)

 

$

(0.16

)

Weighted average number of shares outstanding:

 

 

 

 

 

 

 

 

Basic

 

 

10,423,068

 

 

 

10,251,696

 

 

 

10,421,886

 

 

 

9,737,801

 

Diluted

 

 

10,567,304

 

 

 

10,469,028

 

 

 

10,421,886

 

 

 

9,737,801

 

LIMBACH HOLDINGS, INC.

Condensed Consolidated Balance Sheets (Unaudited)

 

(in thousands, except share and per share data)

June 30, 2022

 

December 31, 2021

ASSETS

 

 

 

Current assets:

 

 

 

Cash and cash equivalents

$

19,630

 

$

14,476

Restricted cash

 

113

 

 

113

Accounts receivable (net of allowance for doubtful accounts of $316 and $263 as of June 30, 2022 and December 31, 2021, respectively)

 

101,018

 

 

89,327

Contract assets

 

74,959

 

 

83,863

Income tax receivable

 

676

 

 

114

Other current assets

 

5,534

 

 

5,013

Total current assets

 

201,930

 

 

192,906

 

 

 

 

Property and equipment, net

 

20,419

 

 

21,621

Intangible assets, net

 

16,109

 

 

16,907

Goodwill

 

11,370

 

 

11,370

Operating lease right-of-use assets

 

16,644

 

 

20,119

Deferred tax asset

 

4,342

 

 

4,330

Other assets

 

231

 

 

259

Total assets

$

271,045

 

$

267,512

 

 

 

 

LIABILITIES

 

 

 

Current liabilities:

 

 

 

Current portion of long-term debt

$

9,893

 

$

9,879

Current operating lease liabilities

 

3,415

 

 

4,366

Accounts payable, including retainage

 

63,205

 

 

63,840

Contract liabilities

 

39,835

 

 

26,712

Accrued income taxes

 

?

 

 

501

Accrued expenses and other current liabilities

 

25,773

 

 

24,444

Total current liabilities

 

142,121

 

 

129,742

Long-term debt

 

24,699

 

 

29,816

Long-term operating lease liabilities

 

14,086

 

 

16,576

Other long-term liabilities

 

1,827

 

 

3,540

Total liabilities

 

182,733

 

 

179,674

Commitments and contingencies

 

 

 

 

 

 

 

STOCKHOLDERS' EQUITY

 

 

 

Common stock, $0.0001 par value; 100,000,000 shares authorized, 10,423,068 issued and outstanding as of June 30, 2022 and 10,304,242 at December 31, 2021

 

1

 

 

1

Additional paid-in capital

 

86,128

 

 

85,004

Retained Earnings

 

2,183

 

 

2,833

Total stockholders' equity

 

88,312

 

 

87,838

Total liabilities and stockholders' equity

$

271,045

 

$

267,512

LIMBACH HOLDINGS, INC.

Condensed Consolidated Statements of Cash Flows (Unaudited)

 

 

Six Months Ended
June 30,

(in thousands)

2022

 

2021

Cash flows from operating activities:

 

 

 

Net loss

$

(650

)

 

$

(1,550

)

Adjustments to reconcile net loss to cash provided by (used in) operating activities:

 

 

 

Depreciation and amortization

 

4,148

 

 

 

2,964

 

Provision for doubtful accounts

 

104

 

 

 

70

 

Stock-based compensation expense

 

1,174

 

 

 

1,313

 

Noncash operating lease expense

 

2,232

 

 

 

2,091

 

Amortization of debt issuance costs

 

65

 

 

 

220

 

Deferred income tax provision

 

(12

)

 

 

(306

)

Gain on sale of property and equipment

 

(111

)

 

 

(8

)

Loss on early termination of operating lease

 

849

 

 

 

?

 

Change in fair value of contingent consideration

 

765

 

 

 

?

 

Loss on early debt extinguishment

 

?

 

 

 

1,961

 

Gain on change in fair value of warrant liability

 

?

 

 

 

(14

)

Changes in operating assets and liabilities:

 

 

 

Accounts receivable

 

(11,796

)

 

 

(8,918

)

Contract assets

 

8,904

 

 

 

(3,717

)

Other current assets

 

(520

)

 

 

(1,306

)

Accounts payable, including retainage

 

(635

)

 

 

190

 

Prepaid income taxes

 

(562

)

 

 

(891

)

Accrued taxes payable

 

(501

)

 

 

(1,671

)

Contract liabilities

 

13,123

 

 

 

(7,469

)

Operating lease liabilities

 

(2,165

)

 

 

(2,004

)

Accrued expenses and other current liabilities

 

(1,861

)

 

 

(5,450

)

Other long-term liabilities

 

69

 

 

 

(114

)

Net cash provided by (used in) operating activities

 

12,620

 

 

 

(24,609

)

Cash flows from investing activities:

 

 

 

Proceeds from sale of property and equipment

 

189

 

 

 

361

 

Purchase of property and equipment

 

(473

)

 

 

(501

)

Net cash used in investing activities

 

(284

)

 

 

(140

)

Cash flows from financing activities:

 

 

 

Proceeds from Wintrust Term Loan

 

?

 

 

 

30,000

 

Payments on Wintrust and A&R Wintrust Term Loans

 

(9,149

)

 

 

(2,000

)

Proceeds from A&R Wintrust Revolving Loan

 

15,194

 

 

 

?

 

Payments on A&R Wintrust Revolving Loan

 

(11,694

)

 

 

?

 

Payments on 2019 Refinancing Term Loan

 

?

 

 

 

(39,000

)

Prepayment penalty and other costs associated with early debt extinguishment

 

?

 

 

 

(1,376

)

Proceeds from the sale of common stock

 

?

 

 

 

22,773

 

Proceeds from the exercise of warrants

 

?

 

 

 

1,989

 

Payments on finance leases

 

(1,358

)

 

 

(1,318

)

Payments of debt issuance costs

 

(25

)

 

 

(593

)

Taxes paid related to net-share settlement of equity awards

 

(363

)

 

 

(401

)

Proceeds from contributions to Employee Stock Purchase Plan

 

213

 

 

 

221

 

Net cash (used in) provided by financing activities

 

(7,182

)

 

 

10,295

 

Increase (decrease) in cash, cash equivalents and restricted cash

 

5,154

 

 

 

(14,454

)

Cash, cash equivalents and restricted cash, beginning of period

 

14,589

 

 

 

42,260

 

Cash, cash equivalents and restricted cash, end of period

$

19,743

 

 

$

27,806

 

Supplemental disclosures of cash flow information

 

 

 

Noncash investing and financing transactions:

 

 

 

Right of use assets obtained in exchange for new operating lease liabilities

$

?

 

 

$

156

 

Right of use assets obtained in exchange for new finance lease liabilities

 

1,968

 

 

 

336

 

Right of use assets disposed or adjusted modifying operating lease liabilities

 

(1,276

)

 

 

36

 

Right of use assets disposed or adjusted modifying finance lease liabilities

 

(77

)

 

 

?

 

Interest paid

 

911

 

 

 

1,741

 

Cash paid for income taxes

$

696

 

 

$

2,096

 

LIMBACH HOLDINGS, INC.

Condensed Consolidated Segment Operating Results (Unaudited)

 

 

Three Months Ended
June 30,

 

Increase/(Decrease)

(in thousands, except for percentages)

2022

 

2021

 

$

 

%

Statement of Operations Data:

 

 

 

 

 

 

 

 

 

 

 

Revenue:

 

 

 

 

 

 

 

 

 

 

 

GCR

$

66,336

 

57.1

%

 

$

87,550

 

72.3

%

 

$

(21,214

)

 

(24.2

) %

ODR

 

49,784

 

42.9

%

 

 

33,469

 

27.7

%

 

 

16,315

 

 

48.7

%

Total revenue

 

116,120

 

100.0

%

 

 

121,019

 

100.0

%

 

 

(4,899

)

 

(4.0

) %

 

 

 

 

 

 

 

 

 

 

 

 

Gross profit:

 

 

 

 

 

 

 

 

 

 

 

GCR(1)

 

8,694

 

13.1

%

 

 

8,885

 

10.1

%

 

 

(191

)

 

(2.1

) %

ODR(2)

 

12,626

 

25.4

%

 

 

9,805

 

29.3

%

 

 

2,821

 

 

28.8

%

Total gross profit

 

21,320

 

18.4

%

 

 

18,690

 

15.4

%

 

 

2,630

 

 

14.1

%

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative:

 

 

 

 

 

 

 

 

 

 

 

GCR(1)

 

7,980

 

12.0

%

 

 

9,070

 

10.4

%

 

 

(1,090

)

 

(12.0

) %

ODR(2)

 

10,135

 

20.4

%

 

 

7,526

 

22.5

%

 

 

2,609

 

 

34.7

%

Corporate

 

575

 

0.5

%

 

 

636

 

0.5

%

 

 

(61

)

 

(9.6

) %

Total selling, general and administrative

 

18,690

 

16.1

%

 

 

17,232

 

14.2

%

 

 

1,458

 

 

8.5

%

 

 

 

 

 

 

 

 

 

 

 

 

Change in fair value of contingent consideration (Corporate)

 

765

 

0.7

%

 

 

?

 

?

%

 

 

765

 

 

100.0

%

Amortization of intangibles (Corporate)

 

399

 

0.3

%

 

 

104

 

0.1

%

 

 

295

 

 

283.7

%

Total operating income

$

1,466

 

1.3

%

 

$

1,354

 

1.1

%

 

$

112

 

 

8.3

%

(1)   

As a percentage of GCR revenue.

(2)   

As a percentage of ODR revenue.

LIMBACH HOLDINGS, INC.

Condensed Consolidated Segment Operating Results (Unaudited)

 

 

Six Months Ended
June 30,

 

Increase/(Decrease)

(in thousands, except for percentages)

2022

 

2021

 

$

 

%

Statement of Operations Data:

 

 

 

 

 

 

 

 

 

 

 

Revenue:

 

 

 

 

 

 

 

 

 

 

 

GCR

$

138,268

 

59.9

%

 

$

172,354

 

73.5

%

 

$

(34,086

)

 

(19.8

) %

ODR

 

92,674

 

40.1

%

 

 

62,009

 

26.5

%

 

 

30,665

 

 

49.5

%

Total revenue

 

230,942

 

100.0

%

 

 

234,363

 

100.0

%

 

 

(3,421

)

 

(1.5

) %

 

 

 

 

 

 

 

 

 

 

 

 

Gross profit:

 

 

 

 

 

 

 

 

 

 

 

GCR(1)

 

17,052

 

12.3

%

 

 

18,280

 

10.6

%

 

 

(1,228

)

 

(6.7

) %

ODR(2)

 

22,608

 

24.4

%

 

 

17,639

 

28.4

%

 

 

4,969

 

 

28.2

%

Total gross profit

 

39,660

 

17.2

%

 

 

35,919

 

15.3

%

 

 

3,741

 

 

10.4

%

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative:

 

 

 

 

 

 

 

 

 

 

 

GCR(1)

 

16,545

 

12.0

%

 

 

18,184

 

10.6

%

 

 

(1,639

)

 

(9.0

) %

ODR(2)

 

19,705

 

21.3

%

 

 

14,880

 

24.0

%

 

 

4,825

 

 

32.4

%

Corporate

 

1,174

 

0.5

%

 

 

1,313

 

0.6

%

 

 

(139

)

 

(10.6

) %

Total selling, general and administrative

 

37,424

 

16.2

%

 

 

34,377

 

14.7

%

 

 

3,047

 

 

8.9

%

 

 

 

 

 

 

 

 

 

 

 

 

Change in fair value of contingent consideration (Corporate)

 

765

 

0.3

%

 

 

?

 

?

%

 

 

765

 

 

100.0

%

Amortization of intangibles (Corporate)

 

798

 

0.3

%

 

 

208

 

0.1

%

 

 

590

 

 

283.7

%

Total operating income

$

673

 

0.3

%

 

$

1,334

 

0.6

%

 

$

(661

)

 

(49.6

) %

(1)   

As a percentage of GCR revenue.

(2)   

As a percentage of ODR revenue.

Non-GAAP Financial Measures

In assessing the performance of our business, management utilizes a variety of financial and performance measures. The key measure is Adjusted EBITDA, a non-GAAP financial measure. We define Adjusted EBITDA as net income plus depreciation and amortization expense, interest expense, and taxes, as further adjusted to eliminate the impact of, when applicable, other non-cash items or expenses that are unusual or non-recurring that we believe do not reflect our core operating results. We believe that Adjusted EBITDA is meaningful to our investors to enhance their understanding of our financial performance for the current period and our ability to generate cash flows from operations that are available for taxes, capital expenditures and debt service. We understand that Adjusted EBITDA is frequently used by securities analysts, investors and other interested parties as a measure of financial performance and to compare our performance with the performance of other companies that report Adjusted EBITDA. Our calculation of Adjusted EBITDA, however, may not be comparable to similarly titled measures reported by other companies. When assessing our operating performance, investors and others should not consider this data in isolation or as a substitute for net income calculated in accordance with GAAP. Further, the results presented by Adjusted EBITDA cannot be achieved without incurring the costs that the measure excludes. A reconciliation of net income to Adjusted EBITDA, the most comparable GAAP measure, is provided below.

We refer to our estimated revenue on uncompleted contracts, including the amount of revenue on contracts for which work has not begun, less the revenue we have recognized under such contracts, as "backlog." Backlog includes unexercised contract options.

Reconciliation of Net Income (Loss) to Adjusted EBITDA

 

 

 

 

 

 

 

 

 

Three Months Ended
June 30,

 

Six Months Ended
June 30,

(in thousands)

2022

 

2021

 

2022

 

2021

Net income (loss)

$

866

 

$

732

 

$

(650

)

 

$

(1,550

)

 

 

 

 

 

 

 

 

Adjustments:

 

 

 

 

 

 

 

Depreciation and amortization

 

2,086

 

 

1,469

 

 

4,148

 

 

 

2,964

 

Interest expense, net

 

478

 

 

452

 

 

964

 

 

 

1,716

 

Non-cash stock-based compensation expense

 

575

 

 

636

 

 

1,174

 

 

 

1,313

 

Loss on early debt extinguishment

 

?

 

 

?

 

 

?

 

 

 

1,961

 

Change in fair value of warrants

 

?

 

 

?

 

 

?

 

 

 

(14

)

Loss on early termination of operating lease

 

32

 

 

?

 

 

849

 

 

 

?

 

Income tax provision (benefit)

 

237

 

 

264

 

 

(379

)

 

 

(771

)

Acquisition and other transaction costs

 

45

 

 

?

 

 

198

 

 

 

?

 

Change in fair value of contingent consideration

 

765

 

 

?

 

 

765

 

 

 

?

 

Restructuring costs(1)

 

1,491

 

 

?

 

 

2,926

 

 

 

?

 

Adjusted EBITDA

$

6,575

 

$

3,553

 

$

9,995

 

 

$

5,619

 

(1)   

Includes restructuring charges within our Southern California and Eastern Pennsylvania branches as well as other cost savings initiatives throughout the company.

 


These press releases may also interest you

at 06:00
The Sabin Vaccine Institute yesterday presented the Albert B. Sabin Gold Medal to physician-researchers Keith Paul Klugman and Shabir Ahmed Madhi, and its Rising Star award to infectious diseases epidemiologist Nicole Elaine Basta at a ceremony in...

at 05:45
The Gross Law Firm issues the following notice to shareholders of Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II ....

at 01:20
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in thedevelopment oftherapeutics for age-related diseases, today annouces that it will change the ratio...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...



News published on and distributed by: